These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29977164)

  • 21. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.
    Shin JI; Secora A; Alexander GC; Inker LA; Coresh J; Chang AR; Grams ME
    Clin J Am Soc Nephrol; 2018 Aug; 13(8):1144-1152. PubMed ID: 30002224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary embolism and deep vein thrombosis in eosinophilic granulomatosis with polyangiitis successfully treated with rivaroxaban.
    Naito T; Hayashi H; Kashiwada T; Saito Y; Abe S; Kubota K; Gemma A
    Respir Med Case Rep; 2018; 25():33-35. PubMed ID: 29998056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation.
    Lamsam L; Sussman ES; Iyer AK; Bhambhvani HP; Han SS; Skirboll S; Ratliff JK
    Stroke; 2018 Aug; 49(8):1866-1871. PubMed ID: 29991654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful Resolution of a Large Left Ventricular Thrombus with Rivaroxaban Therapy after Acute Myocardial Infarction.
    Bhatnagar UB; Rezkalla J; Sethi P; Stys A
    S D Med; 2018 Feb; 71(2):62-63. PubMed ID: 29990412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis.
    Kim YT; Kang MW; Lee JK; Lee YM; Kim JI
    BMC Musculoskelet Disord; 2018 Jul; 19(1):227. PubMed ID: 30021575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.
    Coleman CI; Turpie AGG; Bunz TJ; Eriksson D; Sood NA; Baker WL
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):64-69. PubMed ID: 30020424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis.
    Brunetti ND; Tarantino N; De Gennaro L; Correale M; Santoro F; Di Biase M
    Open Heart; 2018; 5(2):e000785. PubMed ID: 30018775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of Recanalization Therapy in Patients with Acute Ischemic Stroke Under Anticoagulation: A Systematic Review and Meta-Analysis.
    Liu M; Zheng Y; Li G
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2296-2305. PubMed ID: 30017747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
    J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.
    Kent AP; Brueckmann M; Fraessdorf M; Connolly SJ; Yusuf S; Eikelboom JW; Oldgren J; Reilly PA; Wallentin L; Ezekowitz MD
    J Am Coll Cardiol; 2018 Jul; 72(3):255-267. PubMed ID: 30012318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events.
    Nakamura K; Naito S; Sasaki T; Take Y; Minami K; Kitagawa Y; Motoda H; Inoue M; Otsuka Y; Niijima K; Yamashita E; Sugai Y; Kumagai K; Koyama K; Funabashi N; Oshima S
    Europace; 2019 Feb; 21(2):259-267. PubMed ID: 29982562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure.
    Padrini R
    Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):1-12. PubMed ID: 30167998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Betrixaban: A Novel Factor Xa Inhibitor for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients.
    Lee K; Cham S; Lam S
    Cardiol Rev; 2018; 26(6):331-338. PubMed ID: 30067518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta-analysis of prospective studies.
    Minhas H; Welsher A; Turcotte M; Eventov M; Mason S; Nishijima DK; Versmée G; Li M; de Wit K
    Br J Haematol; 2018 Oct; 183(1):119-126. PubMed ID: 30028001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis.
    Horinouchi Y; Ikeda Y; Fukushima K; Imanishi M; Hamano H; Izawa-Ishizawa Y; Zamami Y; Takechi K; Miyamoto L; Fujino H; Ishizawa K; Tsuchiya K; Tamaki T
    Sci Rep; 2018 Jul; 8(1):10858. PubMed ID: 30022146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of dabigatran versus warfarin from the RE-LY trial.
    Avezum A; Oliveira GBF; Diaz R; Hermosillo JAG; Oldgren J; Ripoll EF; Noack H; Piegas LS; Connolly SJ
    Open Heart; 2018; 5(1):e000800. PubMed ID: 30018769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines.
    Sennesael AL; Panin N; Vancraeynest C; Pochet L; Spinewine A; Haufroid V; Elens L
    Sci Rep; 2018 Jul; 8(1):10514. PubMed ID: 30002384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry.
    Boriani G; Proietti M; Laroche C; Diemberger I; Popescu MI; Riahi S; Shantsila A; Dan GA; Tavazzi L; Maggioni AP; Lip GYH;
    Int J Cardiol; 2018 Nov; 271():68-74. PubMed ID: 30001945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulation therapy in patients with stroke and atrial fibrillation: a registry-based study of acute stroke care in Surrey, UK.
    Han TS; Fry CH; Fluck D; Affley B; Gulli G; Barrett C; Kakar P; Patel T; Sharma S; Sharma P
    BMJ Open; 2018 Jul; 8(7):e022558. PubMed ID: 29997144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of combined therapy with catheter-directed thrombolysis and factor Xa inhibitor for inferior vena cava thrombosis: A case report.
    Nonaka D; Takase H; Machii M; Ohno K
    Medicine (Baltimore); 2018 Jul; 97(28):e11221. PubMed ID: 29995753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.